chr16-13935413-TAACTC-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_005236.3(ERCC4):c.1484_1488del(p.Thr495AsnfsTer6) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000171 in 1,460,740 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.000017 ( 0 hom. )
Consequence
ERCC4
NM_005236.3 frameshift
NM_005236.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.72
Genes affected
ERCC4 (HGNC:3436): (ERCC excision repair 4, endonuclease catalytic subunit) The protein encoded by this gene forms a complex with ERCC1 and is involved in the 5' incision made during nucleotide excision repair. This complex is a structure specific DNA repair endonuclease that interacts with EME1. Defects in this gene are a cause of xeroderma pigmentosum complementation group F (XP-F), or xeroderma pigmentosum VI (XP6).[provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-13935413-TAACTC-T is Pathogenic according to our data. Variant chr16-13935413-TAACTC-T is described in ClinVar as [Pathogenic]. Clinvar id is 55823.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr16-13935413-TAACTC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ERCC4 | NM_005236.3 | c.1484_1488del | p.Thr495AsnfsTer6 | frameshift_variant | 8/11 | ENST00000311895.8 | NP_005227.1 | |
ERCC4 | XM_011522424.4 | c.1622_1626del | p.Thr541AsnfsTer6 | frameshift_variant | 9/12 | XP_011520726.1 | ||
ERCC4 | XM_011522427.2 | c.134_138del | p.Thr45AsnfsTer6 | frameshift_variant | 3/6 | XP_011520729.1 | ||
ERCC4 | XM_047433774.1 | c.695_699del | p.Thr232AsnfsTer6 | frameshift_variant | 5/8 | XP_047289730.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ERCC4 | ENST00000311895.8 | c.1484_1488del | p.Thr495AsnfsTer6 | frameshift_variant | 8/11 | 1 | NM_005236.3 | ENSP00000310520 | P1 | |
ENST00000570663.1 | n.218_219+3del | splice_donor_variant, splice_donor_region_variant, non_coding_transcript_exon_variant, intron_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249934Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135208
GnomAD3 exomes
AF:
AC:
2
AN:
249934
Hom.:
AF XY:
AC XY:
1
AN XY:
135208
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1460740Hom.: 0 AF XY: 0.0000165 AC XY: 12AN XY: 726618
GnomAD4 exome
AF:
AC:
25
AN:
1460740
Hom.:
AF XY:
AC XY:
12
AN XY:
726618
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Fanconi anemia complementation group Q Pathogenic:2
Pathogenic, no assertion criteria provided | curation | Leiden Open Variation Database | Oct 03, 2014 | Curator: Arleen D. Auerbach. Submitter to LOVD: Arleen D. Auerbach. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | May 02, 2013 | - - |
Precursor B-cell acute lymphoblastic leukemia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | St. Jude Molecular Pathology, St. Jude Children's Research Hospital | Jul 26, 2018 | This is a frameshift alteration in which coding nucleotides 1484 through 1488 are deleted. This is predicted to change a Threonine to an Asparagine at codon 495, as well as shift the reading frame and result in a premature stop codon 6 amino acids downstream. Classification criteria: PVS1, PS3, PM2, PP1. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at